InnateDB Protein
|
IDBP-4517.5
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
EGLN3
|
Protein Name
|
egl nine homolog 3 (C. elegans)
|
Synonyms
|
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000250457
|
InnateDB Gene
|
IDBG-4515 (EGLN3)
|
Protein Structure
|
|
Function |
Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A. Has a preference for the CODD site for both HIF1A and HIF2A. Hydroxylation on the NODD site by EGLN3 appears to require prior hydroxylation on the CODD site. Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes. EGLN3 is the most important isozyme in limiting physiological activation of HIFs (particularly HIF2A) in hypoxia. Also hydroxylates PKM in hypoxia, limiting glycolysis. Under normoxia, hydroxylates and regulates the stability of ADRB2. Regulator of cardiomyocyte and neuronal apoptosis. In cardiomyocytes, inhibits the anti-apoptotic effect of BCL2 by disrupting the BAX-BCL2 complex. In neurons, has a NGF-induced proapoptotic effect, probably through regulating CASP3 activity. Also essential for hypoxic regulation of neutrophilic inflammation. Plays a crucial role in DNA damage response (DDR) by hydroxylating TELO2, promoting its interaction with ATR which is required for activation of the ATR/CHK1/p53 pathway. Target proteins are preferencially recognized via a LXXLAP motif. {ECO:0000269PubMed:11595184, ECO:0000269PubMed:12181324, ECO:0000269PubMed:16098468, ECO:0000269PubMed:19584355, ECO:0000269PubMed:20849813, ECO:0000269PubMed:20978507, ECO:0000269PubMed:21317538, ECO:0000269PubMed:21483450, ECO:0000269PubMed:21575608, ECO:0000269PubMed:21620138, ECO:0000269PubMed:22797300}.
|
Subcellular Localization |
Nucleus. Cytoplasm. Note=Colocalizes with WDR83 in the cytoplasm. {ECO:0000250}.
|
Disease Associations |
|
Tissue Specificity |
Widely expressed at low levels. Expressed at higher levels in adult heart (cardiac myocytes, aortic endothelial cells and coronary artery smooth muscle), lung and placenta, and in fetal spleen, heart and skeletal muscle. Also expressed in pancreas. Localized to pancreatic acini and islet cells. {ECO:0000269PubMed:12163023, ECO:0000269PubMed:12670503, ECO:0000269PubMed:21575608}.
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 44 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated |
Total |
44
[view]
|
Protein-Protein |
44
[view]
|
Protein-DNA |
0
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
Predicted by orthology |
Total |
3 [view]
|
|
|
Molecular Function |
Accession |
GO Term |
GO:0005506
|
iron ion binding
|
GO:0005515
|
protein binding
|
GO:0016491
|
oxidoreductase activity
|
GO:0016705
|
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
GO:0016706
|
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors
|
GO:0031418
|
L-ascorbic acid binding
|
GO:0031545
|
peptidyl-proline 4-dioxygenase activity
|
|
Biological Process |
GO:0001666
|
response to hypoxia
|
GO:0006915
|
apoptotic process
|
GO:0006919
|
activation of cysteine-type endopeptidase activity involved in apoptotic process
|
GO:0006974
|
cellular response to DNA damage stimulus
|
GO:0018126
|
protein hydroxylation
|
GO:0018401
|
peptidyl-proline hydroxylation to 4-hydroxy-L-proline
|
GO:0042127
|
regulation of cell proliferation
|
GO:0043523
|
regulation of neuron apoptotic process
|
GO:0055114
|
oxidation-reduction process
|
GO:0061418
|
regulation of transcription from RNA polymerase II promoter in response to hypoxia
|
GO:0071456
|
cellular response to hypoxia
|
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR005123
Oxoglutarate/iron-dependent dioxygenase
IPR006620
Prolyl 4-hydroxylase, alpha subunit
|
PFAM |
PF03171
PF13640
|
PRINTS |
|
PIRSF |
|
SMART |
SM00702
|
TIGRFAMs |
|
Modification |
|
SwissProt |
Q9H6Z9
|
PhosphoSite |
PhosphoSite-Q9H6Z9
|
TrEMBL |
Q3T1B0
|
UniProt Splice Variant |
|
Entrez Gene |
112399
|
UniGene |
Hs.674838
|
RefSeq |
NP_071356
|
HUGO |
HGNC:14661
|
OMIM |
606426
|
CCDS |
CCDS9646
|
HPRD |
06972
|
IMGT |
|
EMBL |
AJ310545
AK025273
BC010992
BC064924
BC102030
BC105938
BC105939
BC111057
DQ975379
|
GenPept |
AAH10992
AAH64924
AAI02031
AAI05939
AAI05940
AAI11058
ABM44412
BAB15101
CAC42511
|
|
|